Metamfazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C11H11N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Q0YU79408, chemically known as 3(2h)-pyridazinon, 4-amino-6-methyl-2-phenyl- but generally known as metamfazone, which bears US NIH Compound Identifier 176887. European Medicines Agency schedules Metamfazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08807MIG. The term METAMFAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). METAMFAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metamfazone under HS 29339990 and SITC 51577. As of Q4 2014, METAMFAZONE remains the US FDA Preferred Term for this commodity. Metamfazone bears US NLM identifiers UMLS ID C1881797 and NCI Concept Code C66105. SMILES: CC1=NN(C(=O)C(=C1)N)C2=CC=CC=C2.